Gts Securities LLC Amicus Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $35,256 - $45,825
-3,900 Reduced 27.08%
10,500 $104,000
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $430,911 - $536,848
-37,700 Reduced 72.36%
14,400 $169,000
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $376,866 - $548,856
37,800 Added 264.34%
52,100 $739,000
Q3 2023

Nov 15, 2023
BUY
$11.78 - $13.86 $168,454 - $198,198
14,300 New
14,300 $173,000

Others Institutions Holding FOLD

# of Institutions
278
Shares Held
324M
Call Options Held
260K
Put Options Held
261K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email